To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of the aims of the Cheque for Tech Diabetes funding campaign.
The £559 million technology funding for NHSX announced in the Spending Review is not disease specific but covers the infrastructure and whole pathways work for all major diseases, including diabetes. This investment will support the National Health Service frontline, help fast track innovation and deliver a better experience for patients and staff alike.
In addition to this work and as part of the NHS Long Term Plan, NHS England and NHS Improvement committed to both improving the pipeline of innovation and speeding up the uptake and spread, so that proven and affordable innovations get to patients faster. It sets out a number of specific commitments in relation to the treatment of people living with diabetes and supporting the adoption of new technologies.